(Q38861685)

English

The current state of research on ayahuasca: A systematic review of human studies assessing psychiatric symptoms, neuropsychological functioning, and neuroimaging.

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27287824%20AND%20SRC:MED&resulttype=core&format=json

13 March 2020

1 reference

Europe PubMed Central

The current state of research on ayahuasca: A systematic review of human studies assessing psychiatric symptoms, neuropsychological functioning, and neuroimaging (English)

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27287824%20AND%20SRC:MED&resulttype=core&format=json

13 March 2020

0 references

neuropsychology

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

systematic review

1 reference

based on heuristic

inferred from title

Rafael G Dos Santos

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27287824%20AND%20SRC:MED&resulttype=core&format=json

13 March 2020

José Carlos Bouso

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27287824%20AND%20SRC:MED&resulttype=core&format=json

13 March 2020

author name string

Fermanda M Balthazar

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27287824%20AND%20SRC:MED&resulttype=core&format=json

13 March 2020

Jaime Ec Hallak

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27287824%20AND%20SRC:MED&resulttype=core&format=json

13 March 2020

language of work or name

0 references

publication date

10 June 2016

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27287824%20AND%20SRC:MED&resulttype=core&format=json

13 March 2020

Journal of Psychopharmacology

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27287824%20AND%20SRC:MED&resulttype=core&format=json

13 March 2020

30

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27287824%20AND%20SRC:MED&resulttype=core&format=json

13 March 2020

12

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27287824%20AND%20SRC:MED&resulttype=core&format=json

13 March 2020

1230-1247

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27287824%20AND%20SRC:MED&resulttype=core&format=json

13 March 2020

Serotonergic psychedelics temporarily modify information transfer in humans

1 reference

https://api.crossref.org/works/10.1177%2F0269881116652578

21 January 2018

Effects of harman and harmine on naloxone-precipitated withdrawal syndrome in morphine-dependent rats.

1 reference

https://api.crossref.org/works/10.1177%2F0269881116652578

21 January 2018

A six-month prospective evaluation of personality traits, psychiatric symptoms and quality of life in ayahuasca-naïve subjects

1 reference

https://api.crossref.org/works/10.1177%2F0269881116652578

21 January 2018

Altered states of consciousness and short-term psychological after-effects induced by the first time ritual use of ayahuasca in an urban context in Brazil

1 reference

https://api.crossref.org/works/10.1177%2F0269881116652578

21 January 2018

Health status of ayahuasca users

1 reference

https://api.crossref.org/works/10.1177%2F0269881116652578

21 January 2018

Classical hallucinogens as antidepressants? A review of pharmacodynamics and putative clinical roles

1 reference

https://api.crossref.org/works/10.1177%2F0269881116652578

21 January 2018

Classic hallucinogens in the treatment of addictions

1 reference

https://api.crossref.org/works/10.1177%2F0269881116652578

21 January 2018

Therapeutic mechanisms of classic hallucinogens in the treatment of addictions: from indirect evidence to testable hypotheses

1 reference

https://api.crossref.org/works/10.1177%2F0269881116652578

21 January 2018

Psilocybin-assisted treatment for alcohol dependence: a proof-of-concept study

1 reference

https://api.crossref.org/works/10.1177%2F0269881116652578

21 January 2018

Acute effects of ayahuasca on neuropsychological performance: differences in executive function between experienced and occasional users.

1 reference

https://api.crossref.org/works/10.1177%2F0269881116652578

21 January 2018

Personality, psychopathology, life attitudes and neuropsychological performance among ritual users of Ayahuasca: a longitudinal study

1 reference

https://api.crossref.org/works/10.1177%2F0269881116652578

21 January 2018

Long-term use of psychedelic drugs is associated with differences in brain structure and personality in humans.

1 reference

https://api.crossref.org/works/10.1177%2F0269881116652578

21 January 2018

Harmine augments electrically evoked dopamine efflux in the nucleus accumbens shell

1 reference

https://api.crossref.org/works/10.1177%2F0269881116652578

21 January 2018

Dimethyltryptamine (DMT): subjective effects and patterns of use among Australian recreational users

1 reference

https://api.crossref.org/works/10.1177%2F0269881116652578

21 January 2018

Ayahuasca preparations and serotonin reuptake inhibitors: a potential combination for severe adverse interactions

1 reference

https://api.crossref.org/works/10.1177%2F0269881116652578

21 January 2018

Neural correlates of the psychedelic state as determined by fMRI studies with psilocybin

1 reference

https://api.crossref.org/works/10.1177%2F0269881116652578

21 January 2018

Functional connectivity measures after psilocybin inform a novel hypothesis of early psychosis

1 reference

https://api.crossref.org/works/10.1177%2F0269881116652578

21 January 2018

The entropic brain: a theory of conscious states informed by neuroimaging research with psychedelic drugs

1 reference

https://api.crossref.org/works/10.1177%2F0269881116652578

21 January 2018

Implications for psychedelic-assisted psychotherapy: functional magnetic resonance imaging study with psilocybin.

1 reference

https://api.crossref.org/works/10.1177%2F0269881116652578

21 January 2018

Using psilocybin to investigate the relationship between attention, working memory, and the serotonin 1A and 2A receptors

1 reference

https://api.crossref.org/works/10.1177%2F0269881116652578

21 January 2018

Psilocybin impairs high-level but not low-level motion perception

1 reference

https://api.crossref.org/works/10.1177%2F0269881116652578

21 January 2018

Modulating the rate and rhythmicity of perceptual rivalry alternations with the mixed 5-HT2A and 5-HT1A agonist psilocybin

1 reference

https://api.crossref.org/works/10.1177%2F0269881116652578

21 January 2018

Ayahuasca in adolescence: a preliminary psychiatric assessment

1 reference

https://api.crossref.org/works/10.1177%2F0269881116652578

21 January 2018

Pharmacological modulation of the neural basis underlying inhibition of return (IOR) in the human 5-HT2A agonist and NMDA antagonist model of psychosis

1 reference

https://api.crossref.org/works/10.1177%2F0269881116652578

21 January 2018

Neuronal correlates of visual and auditory alertness in the DMT and ketamine model of psychosis

1 reference

https://api.crossref.org/works/10.1177%2F0269881116652578

21 January 2018

Seeing with the eyes shut: neural basis of enhanced imagery following Ayahuasca ingestion.

1 reference

https://api.crossref.org/works/10.1177%2F0269881116652578

21 January 2018

Ayahuasca in adolescence: a neuropsychological assessment.

1 reference

https://api.crossref.org/works/10.1177%2F0269881116652578

21 January 2018

Report on psychoactive drug use among adolescents using ayahuasca within a religious context

1 reference

https://api.crossref.org/works/10.1177%2F0269881116652578

21 January 2018

Safety and side effects of ayahuasca in humans--an overview focusing on developmental toxicology.

1 reference

https://api.crossref.org/works/10.1177%2F0269881116652578

21 January 2018

A critical evaluation of reports associating ayahuasca with life-threatening adverse reactions

1 reference

https://api.crossref.org/works/10.1177%2F0269881116652578

21 January 2018

Effects of ayahuasca on psychometric measures of anxiety, panic-like and hopelessness in Santo Daime members.

1 reference

https://api.crossref.org/works/10.1177%2F0269881116652578

21 January 2018

Antidepressive and anxiolytic effects of ayahuasca: a systematic literature review of animal and human studies

1 reference

https://api.crossref.org/works/10.1177%2F0269881116652578

21 January 2018

Autonomic, neuroendocrine, and immunological effects of ayahuasca: a comparative study with d-amphetamine.

1 reference

https://api.crossref.org/works/10.1177%2F0269881116652578

21 January 2018

Assessment of addiction severity among ritual users of ayahuasca

1 reference

https://api.crossref.org/works/10.1177%2F0269881116652578

21 January 2018

Acute harmine administration induces antidepressive-like effects and increases BDNF levels in the rat hippocampus.

1 reference

https://api.crossref.org/works/10.1177%2F0269881116652578

21 January 2018

Chronic administration of harmine elicits antidepressant-like effects and increases BDNF levels in rat hippocampus

1 reference

https://api.crossref.org/works/10.1177%2F0269881116652578

21 January 2018

Enhancement of creative expression and entoptic phenomena as after-effects of repeated ayahuasca ceremonies.

1 reference

https://api.crossref.org/works/10.1177%2F0269881116652578

21 January 2018

Effects of ayahuasca on binocular rivalry with dichoptic stimulus alternation

1 reference

https://api.crossref.org/works/10.1177%2F0269881116652578

21 January 2018

Risk assessment of ritual use of oral dimethyltryptamine (DMT) and harmala alkaloids

1 reference

https://api.crossref.org/works/10.1177%2F0269881116652578

21 January 2018

Safety and efficacy of lysergic acid diethylamide-assisted psychotherapy for anxiety associated with life-threatening diseases

1 reference

https://api.crossref.org/works/10.1177%2F0269881116652578

21 January 2018

Serotonin research: contributions to understanding psychoses

1 reference

https://api.crossref.org/works/10.1177%2F0269881116652578

21 January 2018

Effects of iboga alkaloids on morphine and cocaine self-administration in rats: relationship to tremorigenic effects and to effects on dopamine release in nucleus accumbens and striatum

1 reference

https://api.crossref.org/works/10.1177%2F0269881116652578

21 January 2018

Dynamic mapping of human cortical development during childhood through early adulthood

1 reference

https://api.crossref.org/works/10.1177%2F0269881116652578

21 January 2018

Psychedelics and schizophrenia

1 reference

https://api.crossref.org/works/10.1177%2F0269881116652578

21 January 2018

Pilot study of psilocybin treatment for anxiety in patients with advanced-stage cancer

1 reference

https://api.crossref.org/works/10.1177%2F0269881116652578

21 January 2018

Human psychopharmacology of hoasca, a plant hallucinogen used in ritual context in Brazil.

1 reference

https://api.crossref.org/works/10.1177%2F0269881116652578

21 January 2018

Psychological and cognitive effects of long-term peyote use among Native Americans

1 reference

https://api.crossref.org/works/10.1177%2F0269881116652578

21 January 2018

Acute psychological and physiological effects of psilocybin in healthy humans: a double-blind, placebo-controlled dose?effect study

1 reference

https://api.crossref.org/works/10.1177%2F0269881116652578

21 January 2018

Mismatch negativity generation in the human 5HT2A agonist and NMDA antagonist model of psychosis.

1 reference

https://api.crossref.org/works/10.1177%2F0269881116652578

21 January 2018

Prepulse inhibition of the startle reflex and its attentional modulation in the human S-ketamine and N,N-dimethyltryptamine (DMT) models of psychosis.

1 reference

https://api.crossref.org/works/10.1177%2F0269881116652578

21 January 2018

Mescaline-induced psychopathological, neuropsychological, and neurometabolic effects in normal subjects: experimental psychosis as a tool for psychiatric research.

1 reference

https://api.crossref.org/works/10.1177%2F0269881116652578

21 January 2018

CLINICAL SYNDROMES AND BIOCHEMICAL ALTERATIONS FOLLOWING MESCALINE, LYSERGIC ACID DIETHYLAMIDE, PSILOCYBIN AND A COMBINATION OF THE THREE PSYCHOTOMIMETIC DRUGS.

1 reference

https://api.crossref.org/works/10.1177%2F0269881116652578

21 January 2018

Pilot study of the 5-HT2AR agonist psilocybin in the treatment of tobacco addiction

1 reference

https://api.crossref.org/works/10.1177%2F0269881116652578

21 January 2018

Psilocybin biases facial recognition, goal-directed behavior, and mood state toward positive relative to negative emotions through different serotonergic subreceptors

1 reference

https://api.crossref.org/works/10.1177%2F0269881116652578

21 January 2018

Psilocybin-Induced Decrease in Amygdala Reactivity Correlates with Enhanced Positive Mood in Healthy Volunteers

1 reference

https://api.crossref.org/works/10.1177%2F0269881116652578

21 January 2018

Consumption of ayahuasca by children and pregnant women: medical controversies and religious perspectives.

1 reference

https://api.crossref.org/works/10.1177%2F0269881116652578

21 January 2018

Hypotheses regarding the mechanisms of ayahuasca in the treatment of addictions.

1 reference

https://api.crossref.org/works/10.1177%2F0269881116652578

21 January 2018

Therapeutic effects of ritual ayahuasca use in the treatment of substance dependence--qualitative results.

1 reference

https://api.crossref.org/works/10.1177%2F0269881116652578

21 January 2018

Monoamine oxidase inhibitors in South American hallucinogenic plants: tryptamine and beta-carboline constituents of ayahuasca

1 reference

https://api.crossref.org/works/10.1177%2F0269881116652578

21 January 2018

Acute Adverse Reactions to Lsd in Clinical and Experimental use in the United Kingdom

1 reference

https://api.crossref.org/works/10.1177%2F0269881116652578

21 January 2018

Wandering minds: the default network and stimulus-independent thought

1 reference

https://api.crossref.org/works/10.1177%2F0269881116652578

21 January 2018

Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement

1 reference

https://api.crossref.org/works/10.1177%2F0269881116652578

21 January 2018

Chronic treatment with LY341495 decreases 5-HT(2A) receptor binding and hallucinogenic effects of LSD in mice.

1 reference

https://api.crossref.org/works/10.1177%2F0269881116652578

21 January 2018

Broadband cortical desynchronization underlies the human psychedelic state

1 reference

https://api.crossref.org/works/10.1177%2F0269881116652578

21 January 2018

Maternal and developmental toxicity of ayahuasca in Wistar rats.

1 reference

https://api.crossref.org/works/10.1177%2F0269881116652578

21 January 2018

Effects of ayahuasca on the development of ethanol-induced behavioral sensitization and on a post-sensitization treatment in mice.

1 reference

https://api.crossref.org/works/10.1177%2F0269881116652578

21 January 2018

Antidepressant effects of a single dose of ayahuasca in patients with recurrent depression: a preliminary report

1 reference

https://api.crossref.org/works/10.1177%2F0269881116652578

21 January 2018

In vivo comparison of harmine efficacy against psychostimulants: preferential inhibition of the cocaine response through a glutamatergic mechanism

1 reference

https://api.crossref.org/works/10.1177%2F0269881116652578

21 January 2018

The psychedelic state induced by ayahuasca modulates the activity and connectivity of the default mode network

1 reference

https://api.crossref.org/works/10.1177%2F0269881116652578

21 January 2018

Behavioural and neurotoxic effects of ayahuasca infusion (Banisteriopsis caapi and Psychotria viridis) in female Wistar rat.

1 reference

https://api.crossref.org/works/10.1177%2F0269881116652578

21 January 2018

Effects of the South American psychoactive beverage ayahuasca on regional brain electrical activity in humans: a functional neuroimaging study using low-resolution electromagnetic tomography.

1 reference

https://api.crossref.org/works/10.1177%2F0269881116652578

21 January 2018

Metabolism and urinary disposition of N,N-dimethyltryptamine after oral and smoked administration: a comparative study.

1 reference

https://api.crossref.org/works/10.1177%2F0269881116652578

21 January 2018

Effects of ayahuasca on sensory and sensorimotor gating in humans as measured by P50 suppression and prepulse inhibition of the startle reflex, respectively

1 reference

https://api.crossref.org/works/10.1177%2F0269881116652578

21 January 2018

Subjective effects and tolerability of the South American psychoactive beverage Ayahuasca in healthy volunteers

1 reference

https://api.crossref.org/works/10.1177%2F0269881116652578

21 January 2018

Increased frontal and paralimbic activation following ayahuasca, the pan-Amazonian inebriant.

1 reference

https://api.crossref.org/works/10.1177%2F0269881116652578

21 January 2018

Human pharmacology of ayahuasca: subjective and cardiovascular effects, monoamine metabolite excretion, and pharmacokinetics

1 reference

https://api.crossref.org/works/10.1177%2F0269881116652578

21 January 2018

Serotonergic hallucinogens and emerging targets for addiction pharmacotherapies.

1 reference

https://api.crossref.org/works/10.1177%2F0269881116652578

21 January 2018

Banisteriopsis caapi, a unique combination of MAO inhibitory and antioxidative constituents for the activities relevant to neurodegenerative disorders and Parkinson's disease

1 reference

https://api.crossref.org/works/10.1177%2F0269881116652578

21 January 2018

Antidepressant Effects of a Single Dose of Ayahuasca in Patients With Recurrent Depression: A SPECT Study.

1 reference

https://api.crossref.org/works/10.1177%2F0269881116652578

21 January 2018

Microglia sculpt postnatal neural circuits in an activity and complement-dependent manner

1 reference

https://api.crossref.org/works/10.1177%2F0269881116652578

21 January 2018

Acute Biphasic Effects of Ayahuasca

1 reference

https://api.crossref.org/works/10.1177%2F0269881116652578

21 January 2018

Acute Effects of Lysergic Acid Diethylamide in Healthy Subjects.

1 reference

https://api.crossref.org/works/10.1177%2F0269881116652578

21 January 2018

Activities of extract and constituents of Banisteriopsis caapi relevant to parkinsonism

1 reference

https://api.crossref.org/works/10.1177%2F0269881116652578

21 January 2018

Exploring the therapeutic potential of Ayahuasca: acute intake increases mindfulness-related capacities.

1 reference

https://api.crossref.org/works/10.1177%2F0269881116652578

21 January 2018

Drug models of schizophrenia

1 reference

https://api.crossref.org/works/10.1177%2F0269881116652578

21 January 2018

ADVERSE REACTIONS TO PSYCHEDELIC DRUGS. A REVIEW OF THE LITERATURE

1 reference

https://api.crossref.org/works/10.1177%2F0269881116652578

21 January 2018

Dose-response study of N,N-dimethyltryptamine in humans. II. Subjective effects and preliminary results of a new rating scale

1 reference

https://api.crossref.org/works/10.1177%2F0269881116652578

21 January 2018

Acute, subacute and long-term subjective effects of psilocybin in healthy humans: a pooled analysis of experimental studies

1 reference

https://api.crossref.org/works/10.1177%2F0269881116652578

21 January 2018

Switch to mania after ayahuasca consumption in a man with bipolar disorder: a case report

1 reference

https://api.crossref.org/works/10.1177%2F0269881116652578

21 January 2018

Ayahuasca-assisted therapy for addiction: results from a preliminary observational study in Canada

1 reference

https://api.crossref.org/works/10.1177%2F0269881116652578

21 January 2018

Effects of the 5-HT2A agonist psilocybin on mismatch negativity generation and AX-continuous performance task: implications for the neuropharmacology of cognitive deficits in schizophrenia

1 reference

https://api.crossref.org/works/10.1177%2F0269881116652578

21 January 2018

A systems model of altered consciousness: integrating natural and drug-induced psychoses

1 reference

https://api.crossref.org/works/10.1177%2F0269881116652578

21 January 2018

The neurobiology of psychedelic drugs: implications for the treatment of mood disorders

1 reference

https://api.crossref.org/works/10.1177%2F0269881116652578

21 January 2018

Positron emission tomography and fluorodeoxyglucose studies of metabolic hyperfrontality and psychopathology in the psilocybin model of psychosis.

1 reference

https://api.crossref.org/works/10.1177%2F0269881116652578

21 January 2018

Psilocybin induces schizophrenia-like psychosis in humans via a serotonin-2 agonist action

1 reference

https://api.crossref.org/works/10.1177%2F0269881116652578

21 January 2018

Effects of psilocybin on time perception and temporal control of behaviour in humans

1 reference

https://api.crossref.org/works/10.1177%2F0269881116652578

21 January 2018

Identifiers

10.1177/0269881116652578

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27287824%20AND%20SRC:MED&resulttype=core&format=json

13 March 2020

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27287824%20AND%20SRC:MED&resulttype=core&format=json

13 March 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q38861685&oldid=1505211348"